(Q74681820)
Statements
Normal donor bone marrow is superior to Flt3 ligand-mobilized bone marrow in prolonging heart allograft survival when combined with anti-CD40L (CD154) (English)
Holger Hackstein
Zhiliang Wang
Adrian E Morelli
Katsuhiko Kaneko
Takuya Takayama
Bridget L Colvin
Angus W Thomson
1 August 2002